Jeffrey Farrow

Chief Financial Officer

Jeffrey Farrow was most recently Vice President of Finance at Evotec AG, a publicly held drug discovery and development company focused on novel small molecule therapeutics. Prior to Evotec, Mr. Farrow was Vice President of Finance and Chief Accounting Officer at Renovis, Inc., a NASDAQ listed biotech company focused on neurological diseases and disorders, which was acquired by Evotec AG in May 2008. While at Renovis Mr. Farrow was a key member of the management team responsible for the merger with Evotec as well as Renovis’ initial public offering and secondary offering that raised over $115 million. Before joining Renovis Mr. Farrow was a Senior Manager in the audit practice of KPMG LLP. Mr. Farrow holds a B.A. in Business Administration with a concentration in Corporate Finance from California State University at Fullerton.